EuroAPI: Deutsche Bank cuts target price

(CercleFinance.com) - Deutsche Bank maintains its 'sell' recommendation on EuroAPI shares, with a target price reduced from E3 to E2.
5, following the active pharmaceutical ingredients supplier's update on the financing of its medium-term plan.

While the group has reached a non-dilutive agreement for financing from Sanofi, the broker notes that EuroAPI has not provided any concrete medium-term projections on sales or margin, which it sees as a disappointment.

The company reports only E75m to E80m of further improvement in adjusted EBITDA by end-2027 from its 2024 base, while growth is expected to remain moderate for the period, Deutsche Bank adds.


Copyright (c) 2024 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.